Share your biotechnological insights and experiences at our next Biotechnology, Chemical, and Pharmaceutical Partnership (BCP) meeting on Tuesday, March 29, from 9 a.m. to 5 p.m. ET.

Discussion topics will include:

  • Claim construction and doctrine of equivalents
  • Statutory provisions governing patent infringement: A practical analysis
  • Deferred Subject Matter Eligibility Response pilot program (DSMER)
  • Quality metrics
  • Explicit rationales in rejections under 35 U.S.C. 103
  • A systematic approach to 35 U.S.C. 112(b)
  • Sequence search

For questions or more information regarding this event, please email